LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

NCT03684980 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma

Interventions

DRUG: Methotrexate
DRUG: Rituximab
DRUG: leucovorin
DRUG: Glucarpidase

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]